190 related articles for article (PubMed ID: 9403039)
1. Bioactivation of mushroom hydrazines to mutagenic products by mammalian and fungal enzymes.
Walton K; Coombs MM; Walker R; Ioannides C
Mutat Res; 1997 Nov; 381(1):131-9. PubMed ID: 9403039
[TBL] [Abstract][Full Text] [Related]
2. The metabolism and bioactivation of agaritine and of other mushroom hydrazines by whole mushroom homogenate and by mushroom tyrosinase.
Walton K; Coombs MM; Walker R; Ioannides C
Toxicology; 2001 Mar; 161(3):165-77. PubMed ID: 11297805
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of the mushroom hydrazine, agaritine, to intermediates that bind covalently to proteins and induce mutations in the Ames test.
Walton K; Coombs MM; Catterall FS; Walker R; Ioannides C
Carcinogenesis; 1997 Aug; 18(8):1603-8. PubMed ID: 9276636
[TBL] [Abstract][Full Text] [Related]
4. The mutagenic activity of agaritine--a constituent of the cultivated mushroom Agaricus bisporus--and its derivatives detected with the Salmonella/mammalian microsome assay (Ames Test).
Friederich U; Fischer B; Lüthy J; Hann D; Schlatter C; Würgler FE
Z Lebensm Unters Forsch; 1986 Aug; 183(2):85-9. PubMed ID: 2876563
[TBL] [Abstract][Full Text] [Related]
5. Agaritine does not mediate the mutagenicity of the edible mushroom Agaricus bisporus.
Papaparaskeva C; Ioannides C; Walker R
Mutagenesis; 1991 May; 6(3):213-7. PubMed ID: 1679191
[TBL] [Abstract][Full Text] [Related]
6. Contribution of phenolic and quinonoid structures in the mutagenicity of the edible mushroom Agaricus bisporus.
Papaparaskeva-Petrides C; Ioannides C; Walker R
Food Chem Toxicol; 1993 Aug; 31(8):561-7. PubMed ID: 8349201
[TBL] [Abstract][Full Text] [Related]
7. Effect of baking and freeze-drying on the direct and indirect mutagenicity of extracts from the edible mushroom Agaricus bisporus.
Walton K; Walker R; Ioannides C
Food Chem Toxicol; 1998 Apr; 36(4):315-20. PubMed ID: 9651048
[TBL] [Abstract][Full Text] [Related]
8. Microbial mutagenicity of selected hydrazines.
Rogan EG; Walker BA; Gingell R; Nagel DL; Toth B
Mutat Res; 1982 Dec; 102(4):413-24. PubMed ID: 6757742
[TBL] [Abstract][Full Text] [Related]
9. Fate of the mushroom hydrazine agaritine in the rat and mouse.
Walton K; Coombs MM; King LJ; Walker R; Ioannides C
Nutr Cancer; 2000; 37(1):55-64. PubMed ID: 10965520
[TBL] [Abstract][Full Text] [Related]
10. Measurement of a genotoxic hydrazine, agaritine, and its derivatives by HPLC with fluorescence derivatization in the agaricus mushroom and its products.
Nagaokaa MH; Nagaoka H; Kondo K; Akiyama H; Maitani T
Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):922-4. PubMed ID: 16755074
[TBL] [Abstract][Full Text] [Related]
11. Effects of cytosol on mutagenesis induced by N-nitrosodimethylamine, N-nitrosomethylurea and alpha-acetoxy-N-nitrosodimethylamine in different strains of Salmonella: evidence for different ultimate mutagens from N-nitrosodimethylamine.
Guttenplan JB
Carcinogenesis; 1993 May; 14(5):1013-9. PubMed ID: 8504462
[TBL] [Abstract][Full Text] [Related]
12. A cytosolic oxygenase activity involved in the bioactivation of 2-aminofluorene.
Leist M; Ayrton AD; Ioannides C
Toxicology; 1992; 71(1-2):7-20. PubMed ID: 1729770
[TBL] [Abstract][Full Text] [Related]
13. Genetic effects of isoniazid and the relationship to in vivo and in vitro biotransformation.
Braun R; Jäkel HP; Schöneich J
Mutat Res; 1984; 137(2-3):61-9. PubMed ID: 6381996
[TBL] [Abstract][Full Text] [Related]
14. Bacterial mutagenicity of extracts of the baked and raw Agaricus bisporus mushroom.
Toth B; Gannett P; Rogan E; Williamson J
In Vivo; 1992; 6(5):487-90. PubMed ID: 1457740
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic activity of newly synthesized sulfa drugs to Salmonella typhimurium.
Temcharoen P; Nerapattanakid S; Toskulkao C; Glinsukon T; Paovaro C; Ruchirawat S
Mutat Res; 1994 Jun; 321(4):187-95. PubMed ID: 7515156
[TBL] [Abstract][Full Text] [Related]
16. Collaborative study of mutagenicity with Salmonella typhimurium TA102.
Jung R; Engelhart G; Herbolt B; Jäckh R; Müller W
Mutat Res; 1992 Apr; 278(4):265-70. PubMed ID: 1373863
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
[TBL] [Abstract][Full Text] [Related]
18. Studies of the metabolic bioactivation of n-nitrosopyrrolidine in the rat.
Cottrell RC; Blowers SD; Walters DG; Lake BG; Purchase R; Phillips JC; Gangolli SD
Carcinogenesis; 1983; 4(3):311-4. PubMed ID: 6339097
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test.
Ayrton AD; Neville S; Ioannides C
Mutat Res; 1992 Jan; 265(1):1-8. PubMed ID: 1370238
[TBL] [Abstract][Full Text] [Related]
20. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
